Welcome to the Meenach Lab!

We develop novel particle-based formulations for the treatment of pulmonary diseases

Our group seeks to address the drug delivery challenges of nanoparticles associated with overcoming physiological barriers. These barriers include, but are not limited to, the mucosal lining of tissues, tumor parenchyma, and the air-blood barrier within the lungs. This work involves a wide variety of skills involving particle engineering and pharmaceutical sciences such as particle formulation, physicochemical characterization of particle systems, and the development of in vitro cell models for the evaluation of these systems.